Progressive phenotype in primary Sjögren's syndrome-associated interstitial lung diseases: Prognostic significance

R. Sugawara (Osaka, Japan), T. Arai (Osaka, Japan), C. Sugimoto (Osaka, Japan), K. Tachibana (Osaka, Japan), M. Akira (Osaka, Japan), T. Kasai (Osaka, Japan), S. Hayashi (Osaka, Japan), Y. Inoue (Osaka, Japan)

Source: Virtual Congress 2020 – Diagnostic and prognostic markers for disease-associated interstitial lung disease and hypersensitivity pneumonitis
Disease area: Interstitial lung diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
R. Sugawara (Osaka, Japan), T. Arai (Osaka, Japan), C. Sugimoto (Osaka, Japan), K. Tachibana (Osaka, Japan), M. Akira (Osaka, Japan), T. Kasai (Osaka, Japan), S. Hayashi (Osaka, Japan), Y. Inoue (Osaka, Japan). Progressive phenotype in primary Sjögren's syndrome-associated interstitial lung diseases: Prognostic significance. 3541

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Prognostic factors of interstitial lung disease associated with primary Sjögren's syndrome
Source: Annual Congress 2013 –Diffuse parenchymal lung disease I
Year: 2013


Clinical analysis of lung manifestation in Sjögren's syndrome
Source: Annual Congress 2013 –Diffuse parenchymal lung disease II
Year: 2013

Progressive fibrosis is common in patients with Sjögren’s syndrome and Interstitial lung disease
Source: Virtual Congress 2021 – Prognostic markers of disease progression in non-idiopathic pulmonary fibrosis interstitial lung diseases
Year: 2021


Prognostic significance of pathologically proven chronic fibrosing interstitial lung diseases with a progressive phenotype (PF-ILDs): single center retrospective cohort
Source: Virtual Congress 2020 – Diagnostic and prognostic markers for disease-associated interstitial lung disease and hypersensitivity pneumonitis
Year: 2020


Early pulmonary phenotype in Hermansky-Pudlak syndrome: Analysis of the chILD-EU registry
Source: International Congress 2016 – Paediatric bronchology I
Year: 2016


The prognostic factor in patients with myositis-associated interstitial lung disease
Source: International Congress 2014 – ILDs: connective tissue disease
Year: 2014


Cystic lung disease associated with Sjögren's syndrome: 3 cases
Source: Annual Congress 2009 - Various backgrounds in diffuse parenchymal lung disease
Year: 2009

Metabolic syndrome in interstitial lung diseases
Source: International Congress 2015 – IIPs: orphan
Year: 2015

Familial pulmonary fibrosis: Clinical-functional and radiological features
Source: Annual Congress 2013 –Idiopathic pulmonary fibrosis and rarities
Year: 2013

Childhood diffuse parenchymal lung diseases: Diagnosis, treatment and outcome
Source: Annual Congress 2013 –Diffuse parenchymal lung disease I
Year: 2013

Lymphangioleiomyomatosis: Functional and morphological characteristics in 36 patients
Source: Annual Congress 2013 –Clinical respiratory physiology in different diseases
Year: 2013


Lung abnormalities in marfan syndrome: a pathogenetic model of early-onset emphysema?
Source: Annual Congress 2009 - Respiratory physiology
Year: 2009

Clinical significance of autoantibody screening in patients with idiopathic pulmonary fibrosis
Source: Annual Congress 2013 –Diffuse pulmonary fibrosis
Year: 2013

Loss of PTEN induced lung fibroblasts exhibiting similar pathogenic features to cancer cells in idiopathic pulmonary fibrosis
Source: International Congress 2014 – ILDs 2
Year: 2014


Clinical characteristics of patients with unclassifiable interstitial lung disease
Source: International Congress 2015 – New insights into IIPs
Year: 2015

Phenotype heterogeneity in a familial "brain lung thyroid syndrome" related to a novel NKX-2.1 mutation
Source: International Congress 2016 – ILD: from the bench to the bedside
Year: 2016

SP-C deficiency: Three different phenotypes for the same mutation
Source: International Congress 2015 – Paediatric bronchology
Year: 2015

Genetic susceptibilty and manifestation of progressive fibrosing interstitial lung diseases.
Source: Virtual Congress 2020 – New clinical insights into idiopathic pulmonary fibrosis
Year: 2020




Pulmonary involvement in primary Sjögren's syndrome
Source: Eur Respir J 2002; 20: Suppl. 38, 470s
Year: 2002

Prognostic relevance of histologic features in nonspecific interstitial pneumonia (NSIP)
Source: Annual Congress 2013 –Diffuse parenchymal lung disease II
Year: 2013